Market Place
Sourcing Support
Biosplice searches for a path forward osteoarthritis drug fails late-stage study
22 Apr 2024 //
ENDPTS
Biosplice: OA-07 P3 Lorecivivint Data At OARSI, OA-21 12-Wk Results
18 Apr 2024 //
GLOBENEWSWIRE
Biosplice Presents Results from Phase 3 Clinical Trial for Lorecivivint
13 Nov 2023 //
GLOBENEWSWIRE
Samumed & United Therapeutics Announce License Agreement For IPF Drug Candidate
17 Sep 2018 //
PR NEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.